China's Unitree Targets $904 Million in Landmark Humanoid Robot IPO

Unitree’s IPO: First Humanoid Robot Maker Set for Shanghai Listing

Chinese robotics firm Unitree is moving toward an initial public offering on the Shanghai Stock Exchange, setting an indicative price of 150.8 yuan per share and targeting proceeds of 6.1 billion yuan (approximately $904 million). If successful, the listing would make Unitree the first pure-play humanoid robot manufacturer to go public on a domestic Chinese exchange, underscoring the rapid capital-raising appetite in the country's fast-growing embodied intelligence sector.

Unitree was founded in 2016 by engineer Wang Xingxing and first gained attention with relatively low-cost quadruped robots — “robot dogs” — before expanding into humanoid platforms such as the G1, H1, and R1 models. Viral videos of the machines running, dancing, and performing martial arts moves have drawn global interest, placing the company in a competitive field that includes Tesla, Boston Dynamics, and a cluster of well-funded Chinese startups. The company's financials reflect its scaling: revenue surged roughly fourfold in 2025 to nearly 1.7 billion yuan, and adjusted net profit stood around 600 million yuan, indicating the business is already profitable by those metrics.

The IPO arrives amid a broader rush by Chinese humanoid robot developers to tap public markets. Shenzhen-based Leju Robotics, maker of the Kuavo humanoid, filed for a ChiNext listing in May, while Shanghai-based AgiBot — viewed as one of the country's leading humanoid robot manufacturers — initiated preparations for a Hong Kong IPO in July. Together, these moves signal that China’s robotics industry is entering a phase where public equity will play a larger role in funding the expensive development and scaling of humanoid systems.

Inside China’s Humanoid Robot IPO Wave

A Cost Advantage Built on China’s Supply Chain

One of Unitree’s clearest competitive edges is its ability to produce complex robotic systems at relatively low price points. The company leverages China’s deep manufacturing and supplier networks, which cover electric motors, sensors, batteries, and other critical components. This integrated ecosystem allows Unitree to undercut Western rivals on bill-of-materials cost while maintaining headline-grabbing capabilities. However, cost efficiency alone does not guarantee mass adoption; the bulk of current demand still comes from universities and government-backed research projects rather than commercial enterprises.

The Strategic Push for Embodied Intelligence

Unitree’s IPO is tightly linked to Beijing’s ambition to lead in “embodied intelligence” — the fusion of artificial intelligence with physical machines that can perceive, navigate, and interact with the real world. Government policy has actively encouraged investment in robotics and AI, and high investor interest provides a receptive environment for public listings. The sequential IPO filings by Unitree, Leju, and AgiBot are less a coincidence than a deliberate industry push to secure capital while policy momentum and retail enthusiasm remain strong.

Where the Risk Lies: Technology Still in Transition

Despite rapid advances, humanoid robots remain far from reliable, large-scale commercial deployment. The current revenue base is dominated by educational and demonstration use cases, with true factory or household adoption years away at best. Challenges include reliability, the ability to perform dexterous and precise tasks consistently, and the sheer expense of training AI models with real-world data. Companies that go public now are essentially selling a narrative of future demand while still needing to prove that demand can materialize at a profitable scale. This gap between near-term revenues and long-term opportunity is the central risk that Unitree and its peers must navigate once listed.

What Unitree’s IPO Means for Investors and the Robotics Industry

For Investors Watching the Robotics Space

• IPO valuation and use of proceeds: With 6.1 billion yuan targeted, Unitree’s pricing provides a benchmark for humanoid robotics valuations. Examine whether the funds are earmarked for R&D, manufacturing expansion, or AI training infrastructure — capital deployment will signal how far the company is from mass commercial readiness.
• Revenue composition matters: Unitree’s rapid growth has been fueled largely by research and institutional buyers. Investors should monitor post-IPO disclosure of revenue by customer type; a shift toward industrial or consumer clients would be a positive signal of commercial traction.
• Watch the IPO pipeline: Leju Robotics’ ChiNext application and AgiBot’s Hong Kong preparations mean the sector could see multiple listings within a year. Comparative analysis of pricing, technology claims, and financials will become critical as the sector matures into a publicly traded group.

For Industry Competitors and Partners

• Capital access narrows the gap: A successful Unitree IPO arms the company with a war chest to invest in AI models and manufacturing scale that private Chinese peers may struggle to match without similar listings. Smaller robotics firms may feel pressure to accelerate their own funding rounds or IPO plans.
• Supply chain consolidation: Public-market scrutiny will push Unitree to further optimize its component costs and production efficiency, potentially squeezing smaller suppliers while deepening ties with key Chinese electronics and motor manufacturers.